HCMT
BBH icon

Highland Capital Management (Tennessee)’s VanEck Biotech ETF BBH Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-105
Closed -$12K – 328
2015
Q3 		$12K Hold
105
– – ﹤0.01% 475
2015
Q2 		$14K Buy
+105
New +$14K ﹤0.01% 482

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Highland Capital Management (Tennessee)'s BBH Position: Q4 2015 in Review

Highland Capital Management (Tennessee) sold out of VanEck Biotech ETF (BBH) in Q4 2015, closing a stake of 105 shares — an estimated $12K sold.

Highland Capital Management (Tennessee) first reported a position in BBH in Q2 2015 and held it in 2 quarters. The position peaked at $14K in Q2 2015. 90 funds tracked by Wall St. Rank hold BBH as of Q4 2015.

  • Highland Capital Management (Tennessee) reported no remaining VanEck Biotech ETF position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 105 VanEck Biotech ETF shares in Q4 2015, an estimated $12K.
  • Highland Capital Management (Tennessee) first reported a position in VanEck Biotech ETF in Q2 2015 and held it in 2 quarters.
  • Highland Capital Management (Tennessee)'s VanEck Biotech ETF position peaked at $14K in Q2 2015.
  • 90 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2015.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2015, filed 27 Jan 2016.